Cargando…

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder

OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is beneficial for treatment-resistant patients with obsessive-compulsive disorder (OCD). The serotonin transporter gene (SLC6A4) may be associated with OCD. We aimed to determine whether SLC6A4 impacts the beneficial effects of rTMS in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Kai, Fan, Xiwang, Yuan, Jianmin, Yin, Jiajun, Su, Hang, Hashimoto, Kenji, Wang, Guoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612955/ https://www.ncbi.nlm.nih.gov/pubmed/31308670 http://dx.doi.org/10.2147/NDT.S209319

Ejemplares similares

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Nikzad, Faezeh, et al.
Publicado: (2021)

rTMS investigation of resistant Obsessive-Compulsive Related Disorders: Efficacy of targeting the reward system
por: Di Ponzio, Michele, et al.
Publicado: (2023)

Indirect Priming rTMS for Treatment-Resistant Obsessive Compulsive Disorder: A Prospect that Demands Exploration
por: Vidya, KL, et al.
Publicado: (2020)

Reductions in Cortico-Striatal Hyperconnectivity Accompany Successful Treatment of Obsessive-Compulsive Disorder with Dorsomedial Prefrontal rTMS
por: Dunlop, Katharine, et al.
Publicado: (2016)

Serotonin transporter gene polymorphisms & obsessive-compulsive disorder
por: Nicolini, Humberto
Publicado: (2010)

Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study
por: Rostami, Reza, et al.
Publicado: (2020)

Effectiveness of repetitive transcranial magnetic stimulation (rTMS) for the treatment of obsessive-compulsive disorder (OCD): a meta-analysis
por: Garg, Kabir, et al.
Publicado: (2021)

Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive–compulsive disorder at rest
por: Chen, Yunhui, et al.
Publicado: (2016)

A Study of the Efficacy of Pharmacotherapy, rTMS and Cognitive Behavioural Therapy as a Multimodal Therapy Model in the management of Obsessive Compulsive Disorder.
por: Unni, Aditya, et al.
Publicado: (2022)

PS01. Influence of age of onset on serotonin transporters of obsessive-compulsive
por: Lee, Junhee, et al.
Publicado: (2016)

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2019)

rTMS for Tinnitus
por: Folmer, Robert L.
Publicado: (2012)

TOPIC: A Study of the Efficacy of Pharmacotherapy, rTMS and Cognitive Behavioral Therapy as a Multimodal Therapy Model in the management of Obsessive Compulsive Disorder.
por: Unni, Aditya, et al.
Publicado: (2022)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2020)

Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
por: Arrojo-Romero, Manuel, et al.
Publicado: (2013)

Contribution of TMS and rTMS in the Understanding of the Pathophysiology and in the Treatment of Dystonia
por: Lozeron, Pierre, et al.
Publicado: (2016)

Parcel-guided rTMS for depression
por: Moreno-Ortega, M., et al.
Publicado: (2020)

rTMS in mental health disorders
por: Richter, Kneginja, et al.
Publicado: (2023)

Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
por: Thamby, Abel, et al.
Publicado: (2019)

Glutamatergic augmentation strategies in obsessive–compulsive disorder
por: Sheshachala, Karthik, et al.
Publicado: (2019)

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
por: Eissazade, Negin, et al.
Publicado: (2023)

Association of serotonin transporter gene polymorphisms with obsessive-compulsive disorder (OCD) in a south Indian population
por: Tibrewal, Prashant, et al.
Publicado: (2010)

PT614. Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Predictors for rTMS response in chronic tinnitus
por: Lehner, Astrid, et al.
Publicado: (2012)

Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2016)

Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen, Shaw-Ji, et al.
Publicado: (2013)

A little goes a long way: Neurobiological effects of low intensity rTMS and implications for mechanisms of rTMS
por: Moretti, Jessica, et al.
Publicado: (2022)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
por: Velasquez, Juan C., et al.
Publicado: (2013)

Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022)

Short-Term Tinnitus Suppression With Electric-Field Guided rTMS for Individualizing rTMS Treatment: A Technical Feasibility Report
por: Schoisswohl, Stefan, et al.
Publicado: (2020)

A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression
por: Larini, L., et al.
Publicado: (2023)

Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
por: Vakili, Yaghoob, et al.
Publicado: (2015)

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
por: Yamamoto, Haruka, et al.
Publicado: (2012)

Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
por: Eryılmaz, Gül, et al.
Publicado: (2013)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021)

Basic mechanisms of rTMS: Implications in Parkinson's disease
por: Arias-Carrión, Oscar
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_05r8bl7n2a86khmm38jsii7tqo